Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

123 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effectiveness of mRNA Vaccines Against COVID-19 Hospitalization by Age and Chronic Medical Conditions Burden Among Immunocompetent US Adults, March-August 2021.
Lewis NM, Naioti EA, Self WH, Ginde AA, Douin DJ, Keipp Talbot H, Casey JD, Mohr NM, Zepeski A, Gaglani M, Ghamande SA, McNeal TA, Shapiro NI, Gibbs KW, Clark Files D, Hager DN, Shehu A, Prekker ME, Erickson HL, Gong MN, Mohamed A, Henning DJ, Steingrub JS, Peltan ID, Brown SM, Martin ET, Hubel K, Hough CL, Busse LW, Ten Lohuis CC, Duggal A, Wilson JG, Gordon AJ, Qadir N, Chang SY, Mallow C, Rivas C, Babcock HM, Kwon JH, Exline MC, Halasa N, Chappell JD, Lauring AS, Grijalva CG, Rice TW, Rhoads JP, Stubblefield WB, Baughman A, Womack KN, Lindsell CJ, Hart KW, Zhu Y, Schrag SJ, Kobayashi M, Verani JR, Patel MM, Tenforde MW; IVY Network Collaborators. Lewis NM, et al. J Infect Dis. 2022 May 16;225(10):1694-1700. doi: 10.1093/infdis/jiab619. J Infect Dis. 2022. PMID: 34932114 Free PMC article.
Development and validation of a highly sensitive and specific electrochemical assay to quantify anti-SARS-CoV-2 IgG antibodies to facilitate pandemic surveillance and monitoring of vaccine response.
Chiang SH, Tu M, Cheng J, Wei F, Li F, Chia D, Garner O, Chandrasekaran S, Bender R, Strom CM, Wong DTW. Chiang SH, et al. medRxiv [Preprint]. 2020 Nov 16:2020.11.12.20230656. doi: 10.1101/2020.11.12.20230656. medRxiv. 2020. Update in: PLoS One. 2021 Jul 1;16(7):e0251342. doi: 10.1371/journal.pone.0251342 PMID: 33236034 Free PMC article. Updated. Preprint.
Current Testing Strategies for SARS-CoV-2 in the United States.
Cervinski MA, Parnas ML, Buxton BP, Choi J, Garner O, Neath SX, Zreloff JL. Cervinski MA, et al. Clin Chem. 2021 Jul 6;67(7):935-940. doi: 10.1093/clinchem/hvab046. Clin Chem. 2021. PMID: 33822921 Free PMC article. No abstract available.
Multi-center evaluation of the VITEK® MS system for mass spectrometric identification of non-Enterobacteriaceae Gram-negative bacilli.
Manji R, Bythrow M, Branda JA, Burnham CA, Ferraro MJ, Garner OB, Jennemann R, Lewinski MA, Mochon AB, Procop GW, Richter SS, Rychert JA, Sercia L, Westblade LF, Ginocchio CC. Manji R, et al. Among authors: garner ob. Eur J Clin Microbiol Infect Dis. 2014 Mar;33(3):337-46. doi: 10.1007/s10096-013-1961-2. Epub 2013 Sep 10. Eur J Clin Microbiol Infect Dis. 2014. PMID: 24019163
Effectiveness of Monovalent mRNA Vaccines Against COVID-19-Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States - IVY Network, 18 States, December 26, 2021-August 31, 2022.
Surie D, Bonnell L, Adams K, Gaglani M, Ginde AA, Douin DJ, Talbot HK, Casey JD, Mohr NM, Zepeski A, McNeal T, Ghamande S, Gibbs KW, Files DC, Hager DN, Shehu A, Frosch AP, Erickson HL, Gong MN, Mohamed A, Johnson NJ, Srinivasan V, Steingrub JS, Peltan ID, Brown SM, Martin ET, Khan A, Bender WS, Duggal A, Wilson JG, Qadir N, Chang SY, Mallow C, Rivas C, Kwon JH, Exline MC, Lauring AS, Shapiro NI, Halasa N, Chappell JD, Grijalva CG, Rice TW, Stubblefield WB, Baughman A, Womack KN, Hart KW, Swan SA, Zhu Y, DeCuir J, Tenforde MW, Patel MM, McMorrow ML, Self WH; IVY Network. Surie D, et al. MMWR Morb Mortal Wkly Rep. 2022 Oct 21;71(42):1327-1334. doi: 10.15585/mmwr.mm7142a3. MMWR Morb Mortal Wkly Rep. 2022. PMID: 36264830 Free PMC article.
Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021-April 2022.
Lewis NM, Murray N, Adams K, Surie D, Gaglani M, Ginde AA, McNeal T, Ghamande S, Douin DJ, Talbot HK, Casey JD, Mohr NM, Zepeski A, Shapiro NI, Gibbs KW, Files DC, Hager DN, Ali H, Prekker ME, Frosch AE, Exline MC, Gong MN, Mohamed A, Johnson NJ, Srinivasan V, Steingrub JS, Peltan ID, Brown SM, Martin ET, Monto AS, Lauring AS, Khan A, Hough CL, Busse LW, Bender W, Duggal A, Wilson JG, Gordon AJ, Qadir N, Chang SY, Mallow C, Rivas C, Babcock HM, Kwon JH, Chappell JD, Halasa N, Grijalva CG, Rice TW, Stubblefield WB, Baughman A, Lindsell CJ, Hart KW, Rhoads JP, McMorrow ML, Tenforde MW, Self WH, Patel MM; Influenza and Other Viruses in the Acutely Ill (IVY) Network. Lewis NM, et al. Open Forum Infect Dis. 2022 Dec 31;10(1):ofac698. doi: 10.1093/ofid/ofac698. eCollection 2023 Jan. Open Forum Infect Dis. 2022. PMID: 36695662 Free PMC article.
123 results